Editors' ChoiceCancer

Papers of note in Science 355 (6320)

See allHide authors and affiliations

Sci. Signal.  10 Jan 2017:
Vol. 10, Issue 461, eaam7192
DOI: 10.1126/scisignal.aam7192

This week’s articles demonstrate that prostate cancer cells become resistant to androgen-deprivation therapy by changing their identity.

CANCER

Evading cancer drugs by identity fraud

Mu et al. and Ku et al. report that prostate cancer cells escape androgen deprivation therapy by morphing into a cell type that does not require androgens.

Highlighted Articles

View Abstract

Navigate This Article